nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—Stomach ache—Cyclosporine—focal segmental glomerulosclerosis	0.0912	0.0912	CcSEcCtD
Amphetamine—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0598	0.0598	CcSEcCtD
Amphetamine—Digestion impaired—Cyclosporine—focal segmental glomerulosclerosis	0.058	0.058	CcSEcCtD
Amphetamine—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.0429	0.0429	CcSEcCtD
Amphetamine—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0426	0.0426	CcSEcCtD
Amphetamine—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.0306	0.0306	CcSEcCtD
Amphetamine—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.0303	0.0303	CcSEcCtD
Amphetamine—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.0279	0.0279	CcSEcCtD
Amphetamine—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.0277	0.0277	CcSEcCtD
Amphetamine—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.0267	0.0267	CcSEcCtD
Amphetamine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.0257	0.0257	CcSEcCtD
Amphetamine—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.022	0.022	CcSEcCtD
Amphetamine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.0216	0.0216	CcSEcCtD
Amphetamine—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.0214	0.0214	CcSEcCtD
Amphetamine—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.0213	0.0213	CcSEcCtD
Amphetamine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0211	0.0211	CcSEcCtD
Amphetamine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.0166	0.0166	CcSEcCtD
Amphetamine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.0165	0.0165	CcSEcCtD
Amphetamine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.0159	0.0159	CcSEcCtD
Amphetamine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.0156	0.0156	CcSEcCtD
Amphetamine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.0155	0.0155	CcSEcCtD
Amphetamine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.0147	0.0147	CcSEcCtD
Amphetamine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.0146	0.0146	CcSEcCtD
Amphetamine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.0144	0.0144	CcSEcCtD
Amphetamine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.0144	0.0144	CcSEcCtD
Amphetamine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.0141	0.0141	CcSEcCtD
Amphetamine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.0138	0.0138	CcSEcCtD
Amphetamine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.0137	0.0137	CcSEcCtD
Amphetamine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.0134	0.0134	CcSEcCtD
Amphetamine—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.0132	0.0132	CcSEcCtD
Amphetamine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.0125	0.0125	CcSEcCtD
Amphetamine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0123	CcSEcCtD
Amphetamine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0123	CcSEcCtD
Amphetamine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.0122	0.0122	CcSEcCtD
Amphetamine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.012	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0119	CcSEcCtD
Amphetamine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0119	CcSEcCtD
Amphetamine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0118	CcSEcCtD
Amphetamine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0113	CcSEcCtD
Amphetamine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.011	0.011	CcSEcCtD
Amphetamine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0109	CcSEcCtD
Amphetamine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0109	0.0109	CcSEcCtD
Amphetamine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.0102	0.0102	CcSEcCtD
Amphetamine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00992	0.00992	CcSEcCtD
Amphetamine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00946	0.00946	CcSEcCtD
Amphetamine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00915	0.00915	CcSEcCtD
Amphetamine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00879	0.00879	CcSEcCtD
Amphetamine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00872	0.00872	CcSEcCtD
Amphetamine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00871	0.00871	CcSEcCtD
Amphetamine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00866	0.00866	CcSEcCtD
Amphetamine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00821	0.00821	CcSEcCtD
